메뉴 건너뛰기
Journal of Clinical Oncology
Volumn 26, Issue 33, 2008, Pages 5486-
Interaction between statins and rituximab in non-Hodgkin's lymphoma
Author keywords

[No Author keywords available]
Indexed keywords

CD20 ANTIBODY; DOXORUBICIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; RITUXIMAB;
EID: 56749105769     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.2008.19.2849     Document Type: Letter
Times cited : (9)
References (3)
  • 1
    • 49249093683 scopus 로고    scopus 로고
    • Doxorubicin cardiotoxicity in the elderly: Old drugs and new opportunities
    • Carver JR, Schuster SJ, Glick JH: Doxorubicin cardiotoxicity in the elderly: Old drugs and new opportunities. J Clin Oncol 26:3122-3124, 2008
    • (2008) J Clin Oncol , vol.26 , pp. 3122-3124
    • Carver, J.R.1    Schuster, S.J.2    Glick, J.H.3
  • 2
    • 41549118473 scopus 로고    scopus 로고
    • Statins impair antitumor effects of rituximab by inducing conformational changes of CD20
    • Winiarska M, Bil J, Wilczek E, et al: Statins impair antitumor effects of rituximab by inducing conformational changes of CD20. PLoS Med 5:e64, 2008
    • (2008) PLoS Med , vol.5
    • Winiarska, M.1    Bil, J.2    Wilczek, E.3
  • 3
    • 39749182212 scopus 로고    scopus 로고
    • A decade of rituximab: Improving survival outcomes in non-Hodgkin's lymphoma
    • Molina A: A decade of rituximab: Improving survival outcomes in non-Hodgkin's lymphoma. Annu Rev Med 59:237-250, 2008
    • (2008) Annu Rev Med , vol.59 , pp. 237-250
    • Molina, A.1

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.